JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Value ETF
IVE
|
+$2.05B |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$1.92B |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.13B |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$1.1B |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.24B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.12B |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$989M |
| 4 |
Microsoft
MSFT
|
+$973M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$931M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.54% |
| 2 | Technology | 14.97% |
| 3 | Healthcare | 10.91% |
| 4 | Financials | 10.87% |
| 5 | Consumer Discretionary | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1701
United Therapeutics
UTHR
$23.4B
| $9.57M | ﹤0.01% |
100,961
-495
| -0.5% | -$47K |
2013 Q2
27 quarters
|
|
1702
CALL
Goldman Sachs
GS
$261B
| $9.57M | ﹤0.01% |
61,900
-64,900
| -51% | -$13.8M |
2016 Q4
13 quarters
|
|
1703
ZTO Express
ZTO
$14.8B
| $9.56M | ﹤0.01% |
361,124
-31,978
| -8% | -$775K |
2016 Q4
13 quarters
|
|
1704
Ulta Beauty
ULTA
$23.4B
| $9.51M | ﹤0.01% |
54,145
+16,272
| +43% | +$4.06M |
2013 Q2
27 quarters
|
|
1705
PUT
Chevron
CVX
$406B
| $9.5M | ﹤0.01% |
131,100
-94,500
| -42% | -$9.34M |
2013 Q2
27 quarters
|
|
1706
Incyte
INCY
$23B
| $9.48M | ﹤0.01% |
129,484
-73,464
| -36% | -$5.55M |
2013 Q2
27 quarters
|
|
1707
Navient
NAVI
$851M
| $9.48M | ﹤0.01% |
1,250,499
+630,700
| +102% | +$7.53M |
2014 Q2
23 quarters
|
|
|
GMS
1708
DELISTED
GMS Inc
GMS
| $9.46M | ﹤0.01% |
601,684
-33,267
| -5% | -$788K |
2016 Q4
13 quarters
|
|
|
QTS
1709
DELISTED
QTS REALTY TRUST, INC.
QTS
| $9.46M | ﹤0.01% |
163,113
+2,800
| +2% | +$156K |
2015 Q1
20 quarters
|
|
1710
Hanover Insurance
THG
$7.72B
| $9.46M | ﹤0.01% |
104,401
+438
| +0.4% | +$54.2K |
2013 Q2
27 quarters
|
|
1711
Malibu Boats
MBUU
$446M
| $9.45M | ﹤0.01% |
328,120
-30,235
| -8% | -$1.2M |
2014 Q1
24 quarters
|
|
|
MNDT
1712
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $9.44M | ﹤0.01% |
892,500
+599,698
| +205% | +$8.62M |
2013 Q4
25 quarters
|
|
1713
Westlake Corp
WLK
$8.4B
| $9.43M | ﹤0.01% |
247,133
+229,570
| +1,307% | +$12.9M |
2013 Q2
27 quarters
|
|
1714
Travel + Leisure Co
TNL
$3.8B
| $9.43M | ﹤0.01% |
434,338
-57,669
| -12% | -$2.4M |
2013 Q2
27 quarters
|
|
1715
CALL
IBM
IBM
$208B
| $9.42M | ﹤0.01% |
88,805
-183,678
| -67% | -$23.2M |
2016 Q1
16 quarters
|
|
|
GHY
1716
PGIM Global High Yield Fund
GHY
$438M
| $9.41M | ﹤0.01% |
850,541
| – | – |
2015 Q4
17 quarters
|
|
1717
CALL
Delta Air Lines
DAL
$55.1B
| $9.38M | ﹤0.01% |
328,900
-267,300
| -45% | -$13.2M |
2015 Q4
17 quarters
|
|
|
MRTX
1718
CALL
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $9.38M | ﹤0.01% |
122,000
+87,000
| +249% | +$7.8M |
2019 Q4
1 quarter
|
|
1719
LPL Financial
LPLA
$26.2B
| $9.36M | ﹤0.01% |
172,034
+65,774
| +62% | +$5.3M |
2015 Q1
20 quarters
|
|
|
RSX
1720
DELISTED
VanEck Russia ETF
RSX
| $9.34M | ﹤0.01% |
559,964
-356,435
| -39% | -$7.96M |
2014 Q3
22 quarters
|
|
|
TPC
1721
Tutor Perini Cor
TPC
$4.63B
| $9.32M | ﹤0.01% |
1,387,665
+962,730
| +227% | +$10.3M |
2013 Q2
27 quarters
|
|
|
DLPH
1722
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
| $9.31M | ﹤0.01% |
1,157,102
+128,213
| +12% | +$1.59M |
2017 Q4
9 quarters
|
|
1723
CNX Resources
CNX
$4.78B
| $9.31M | ﹤0.01% |
1,749,512
-465,836
| -21% | -$3.1M |
2013 Q2
27 quarters
|
|
1724
Vanguard S&P 500 Value ETF
VOOV
$6.61B
| $9.3M | ﹤0.01% |
99,728
+87,425
| +711% | +$10M |
2017 Q4
9 quarters
|
|
|
DHR.PRA
1725
DELISTED
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
| $9.3M | ﹤0.01% |
8,999
-1,058
| -11% | -$1.22M |
2019 Q2
3 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2020 Portfolio in Review
As of Q1 2020, JP Morgan Chase held 6,012 positions worth $426B, down 21% from $536B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase deployed $14B of net new capital in Q1 2020, opening 362 new positions and adding to 2,382 existing holdings. Its largest new stake was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was JPMorgan BetaBuilders Japan ETF, an estimated $1.24B trimmed.
- JP Morgan Chase's largest Q1 2020 buy was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
- JP Morgan Chase added most to iShares S&P 500 Value ETF in Q1 2020, an estimated $2.05B increase.
- JP Morgan Chase's biggest Q1 2020 reduction was JPMorgan BetaBuilders Japan ETF, cutting an estimated $1.24B.
- JP Morgan Chase fully exited Liberty Property Trust in Q1 2020, selling an estimated $264M.
- JP Morgan Chase's ten largest holdings make up 18% of its $426B portfolio in Q1 2020.
- JP Morgan Chase opened 362 new positions and closed 692 in Q1 2020.
- JP Morgan Chase's portfolio value fell 21% quarter-over-quarter to $426B.
Based on JP Morgan Chase's 13F filing for Q1 2020, filed 12 May 2020.